Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Huelva – page 3

86 clinical trials in Huelva, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Huelva at a glance
86
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

86 trials in Huelva

Open in trial search

A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:LTP001
  • Sponsor:Novartis Pharma AG

Cardiomyopathy

Recruiting

Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study on the Effectiveness of Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5 to 11 Years

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Gaxilose
  • Sponsor:Venter Pharma S.L.

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acoramidis Hydrochloride
  • Sponsor:Eidos Therapeutics Inc.

Bronchiectasis

Recruiting

Study on the Effects of Ensifentrine for Patients with Non-Cystic Fibrosis Bronchiectasis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ensifentrine

Ovarian cancer+2

Recruiting

Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:TUB-040
  • Sponsor:Gilead Sciences Inc.

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Insel Gruppe AG

Study on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Alisertib Sodium
  • Sponsor:Puma Biotechnology Inc.

Study on the Effectiveness of Clopidogrel, Prasugrel, and Ticagrelor in Patients with Coronary Acute Syndrome Using VerifyNow Device

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Fundacion Epic

Breast cancer

Recruiting

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Type 2 diabetes mellitus

Not yet recruiting

Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Alogliptin
  • Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Huelva

What the registry says about research in the country

01 Cardiovascular Research

Clinical trials focusing on cardiovascular diseases include studies evaluating new treatments for coronary artery disease and innovative approaches to prevent major cardiovascular events. Research encompasses antiplatelet therapy optimization and novel lipid-lowering interventions.

  • Coronary Artery Disease Management
  • Cardiovascular Event Prevention
  • Antiplatelet Therapy Studies
02 Oncology Studies

Groundbreaking research in cancer treatment addresses multiple types of malignancies, with particular focus on breast cancer and lung cancer. Studies evaluate innovative therapies including immunotherapy combinations and targeted treatments.

  • Breast Cancer Therapeutics
  • Lung Cancer Treatments
  • Pancreatic Cancer Research
03 Gastrointestinal Disorders

Research initiatives in inflammatory bowel diseases focus on novel therapeutic approaches for Crohn's disease and ulcerative colitis. Studies evaluate new medications aimed at improving disease management and patient outcomes.

  • Crohn's Disease Therapies
  • Ulcerative Colitis Treatment
  • Digestive System Disorders
04 Neurodegenerative Conditions

Studies focusing on Alzheimer's disease and other neurodegenerative conditions aim to evaluate new therapeutic approaches for early intervention and disease modification.

  • Early Alzheimer's Treatment
  • Disease-Modifying Therapies
  • Cognitive Function Studies
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.